SeaStar Medical Holding Corporation (ICU) Fair Value 2026

ICU · Biotechnology · 2026-08-28

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.3 /10

32 fundamental signals · 0 models active

Value Trap Risk

LOW (37/100)

Quick Summary — As of 2026-08-28, SeaStar Medical Holding Corporation (ICU) trades at $3.09. QOC: 5.3/10. Value Trap Risk: 37/100 (LOW). 0/13 models active.

Key Facts

Ticker: ICU
Price: $3.09
Quality Score: 5.3/10
Value Trap Risk: 37/100
Models Active: 0/13
Last Updated: 2026-08-28

Strength: 0 independent models provide multi-angle coverage

Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give ICU?

0 Intrinsic Value Models vs. Current Price ($3.09)

Core Models (Unlocked)
Model	Fair Value	Upside

All Models Active

All 0 models are displayed above.

What Is SeaStar Medical Holding Corporation (ICU) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, SeaStar Medical Holding Corporation currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About ICU?

0 of 13 models are currently active for ICU. See which stocks rank higher →

How Does ICU Rank in Biotechnology?

Among 625 Biotechnology stocks, ICU ranks #251 by Quality of Company score. CirclFi's QOC score of 5.3/10 evaluates 32 fundamental signals. A score of 5.3 reflects mixed fundamentals.

See all Most Undervalued Biotechnology Stocks →

Within the Biotechnology space, SeaStar Medical Holding Corporation competes in an environment where partnership revenue often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is ICU a Value Trap?

CirclFi's Value Trap algorithm assigns ICU a score of 37/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for SeaStar Medical Holding Corporation. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, SeaStar Medical Holding Corporation's fundamental quality profile registers 5.3/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ICU valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy SeaStar Medical Holding Corporation Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Biotechnology Stocks Should You Also Analyze?

11 related Biotechnology stocks with 13-model coverage

PLURPluri Inc.QOC 5.3 KZIAKazia Therapeutics LimitedQOC 5.3 APGEApogee Therapeutics, Inc.QOC 5.3 PROKProKidney Corp.QOC 5.3 ACOGAlpha Cognition Inc. Common StockQOC 5.3 CAMPCAMP4 THERAPEUTICS CORPORATIONQOC 5.3 ERASErasca, Inc.QOC 4.7 KALAKALA BIO, Inc.QOC 3.7 DYAIDyadic International, Inc.QOC 6.5 EXELExelixis, Inc.QOC 9.6 INCYIncyte CorporationQOC 9.5

Read investment analysis: PLUR · KZIA · APGE · PROK · ACOG · CAMP · ERAS · KALA · DYAI · EXEL · INCY

Which Other Stocks Have a Similar Quality Score to ICU?

4 companies across all industries closest to ICU’s Quality of Company score of 5.3/10.

LEENLeopard Energy, Inc.QOC 5.3 EUenCore Energy Corp.QOC 5.3 VWAVVisionWave Holdings, Inc.QOC 5.3 NVDANVIDIA CorporationQOC 10.0

Read investment analysis: LEEN · EU · VWAV · NVDA

Where Does ICU Sit in CirclFi's Biotechnology Rankings?

ICU is ranked against every other Biotechnology stock CirclFi covers in each of these screens.

See all Biotechnology stocks ranked →

What Else Do Investors Ask About SeaStar Medical Holding Corporation’s Valuation?

What is SeaStar Medical Holding Corporation's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for SeaStar Medical Holding Corporation (ICU). The Quality of Company score is 5.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ICU overvalued or undervalued right now?

At $3.09, 0 of 0 active models suggest ICU may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits SeaStar Medical Holding Corporation's business model in Biotechnology.

What does a Quality of Company score of 5.3 mean for ICU?

SeaStar Medical Holding Corporation's QOC of 5.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on ICU?

CirclFi analyzes ICU with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is ICU a value trap in 2026?

SeaStar Medical Holding Corporation's Value Trap score is 37/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns SeaStar Medical Holding Corporation (ICU) a Quality of Company score of 5.3/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/ICU/ · Methodology

Primary sources for this ICU valuation

Financial statements: SeaStar Medical Holding Corporation 10-K and 10-Q filings on SEC EDGAR (CIK 0001831868) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ICU as of 2026-08-28; valuations recomputed 2026-08-28.